Aligos Therapeutics is heralding a mid-stage win in metabolic-dysfunction associated steatohepatitis (MASH) after three ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Achilles Therapeutics has torn up its strategy. The British biotech is stopping work on its clinical-phase cell therapy, ...

Vanda Pharmaceuticals has failed to persuade the FDA to approve its gastroparesis candidate on the strength of a phase 3 ...

With COVID-19 still spreading and mpox emerging as a public health emergency of international concern, the National ...

The fall flurry of biotech IPOs shows no signs of abating, with Upstream Bio becoming the latest company to express an ...

GC Therapeutics has entered gameplay with the mission of unlocking a new generation of cell therapies, uploading with $75 ...